US biotech Response Pharmaceuticals (Nasdaq: RSPN) has unveiled top-line Phase II results for its experimental obesity ...

Results from a Phase II trial (NCT06640972) showed that patients treated with RDX-002 experienced significant reductions in ...

Response is also considering running trials of the weight management drug RDX-002 in combination with GLP-1RA therapies.

Response Pharmaceuticals has shared phase 2 data in post-GLP-1 patients, linking its ex-Sanofi asset to reductions in ...

RDX-002, a novel iMTP inhibitor, showed promising results in a Ph2 study, reducing blood fat and weight regain after GLP-1 ...

Taking weight off with a glucagon-like peptide-1 (GLP-1) receptor agonist and keeping it off once the drug has been discontinued has been a tall order but Response Pharmaceuticals Inc. is seeing ...

Among the prominent players are Intrabio Inc., Niagen Bioscience Inc., and Quince Therapeutics Inc. Typically, A-T is first diagnosed before the age of 5 as children begin to develop an altered gait.

The sixth-generation network is expected to achieve global coverage based on the space-air-ground integrated network, and the latest satellite network will play an important role in it. The ...

On NIA court acquitting all the accused in the Malegaon Blast case, AIMIM MP Asaduddin Owaisi says, "... After 17 years, all the accused were acquitted. The Maharashtra government went to the Supreme ...

Elden Ring Nightreign update 1.002 (ver. 1.002.000) is now out on consoles and PC, and this finally adds two-player Expeditions for players who can’t find a third friend (or just don’t want to). There ...

On NIA court acquitting all the accused in the Malegaon Blast case, AIMIM MP Asaduddin Owaisi says, "... After 17 years, all the accused were acquitted. The Maharashtra government went to the ...